Life Technologies | Eiendeler



Assets Endring Dato
Ardelyx USD 435.75M 67.89M 2024-12
Biogen USD 28.05B 263.9M 2024-12
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
Cipla INR 346.55B 19.37B 2024-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 123.52M 13.35M 2024-09
CSL USD 38.02B 718M 2024-06
Galapagos EUR 4.14B 36.48M 2024-12
GlaxoSmithKline GBP 59.46B 1.41B 2024-12
Grifols EUR 21.41B 1.12B 2024-12
Life Technologies USD 91.62M 14.32M 2024-09
Novartis USD 102.25B 1.28B 2024-12
Roche Holding CHF 101.8B 6.02B 2024-12
United Therapeutics USD 7.36B 240.9M 2024-12



Life Technologies Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.